Subcutaneous Lavage in Cesarean Section
Launched by HADASSAH MEDICAL ORGANIZATION · Jun 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether using an antiseptic wash on the skin before closing up after a cesarean section can help reduce the chances of infection at the surgical site. Researchers want to find out if this washing method not only lowers infection rates but also improves the healing of scars, shortens hospital stays, and reduces the likelihood of fever or needing to come back to the hospital after surgery. While this washing technique is already common in other types of surgeries and has shown benefits, this is the first time it's being tested specifically for cesarean deliveries.
To participate in this trial, women who are pregnant and planning to have a cesarean delivery can sign up. Those who join will receive either the antiseptic washing treatment or no treatment at all, and will then follow up at a postpartum clinic about 30 days after their surgery to see how they are doing. The trial is currently looking for participants, and it's a great opportunity to contribute to research that could improve care for future mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant women undergoing cesarean delivery
- Exclusion Criteria:
- • pregnant women undergoing vaginal delivery
About Hadassah Medical Organization
Hadassah Medical Organization (HMO) is a leading healthcare institution based in Jerusalem, Israel, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, HMO leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research across various therapeutic areas. The organization is dedicated to fostering collaboration between clinical researchers, healthcare professionals, and academic institutions, ensuring the highest standards of ethical practice and scientific rigor. HMO's mission is to translate groundbreaking research into effective treatments, ultimately enhancing health outcomes for diverse populations both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported